| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.41 | 0.004 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.48 | 0.005 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |